Oral Sulopenem-etzadroxil/Probenecid Versus Ciprofloxacin for Uncomplicated Urinary Tract Infection in Adult Women
Status:
Completed
Trial end date:
2020-01-20
Target enrollment:
Participant gender:
Summary
This is a prospective, Phase 3, randomized, multi-center, double-blind study of the efficacy,
tolerability, and safety of oral sulopenem-etzadroxil/probenecid versus oral ciprofloxacin
for treatment of uncomplicated urinary tract infection (uUTI) in adult women
Phase:
Phase 3
Details
Lead Sponsor:
Iterum Therapeutics, International Limited Iterum Therapeutics, US Limited